BCLAF1 and disease arising from reactivation of latent virus: In addition, US3 could interfere type I interferon reaction by degrading Bcl-2 associated transcription factor 1 (Bclaf1), and inhibit with MHC I-mediated antigen presentation, which can promote the establishment of latent infection in PRV to some extent [28,29,30].